So, if that S-head article is correct and there's been no disease progression for six months then they're already outperforming the only other competitor, it doesn't matter if the six months is at the start or end of the treatment, it still amounts to more time.
Ann: Stable Patient in MND trial reaches 6-months on MPL, page-29
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 16.5¢ | $276.1K | 1.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 379426 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |